HF
KRRO icon

HRT Financial’s Korro Bio KRRO Stock Holding History

HRT Financial’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,790
Closed -$122K – 4821
2026
Q1 		$122K Buy
+10,790
New +$119K ﹤0.01% 3310
2025
Q1 		– Sell
-5,703
Closed -$217K – 2980
2024
Q4 		$217K Sell
5,703
-939
-14% -$48.3K ﹤0.01% 1891
2024
Q3 		$221K Sell
6,642
-25,882
-80% -$1.09M ﹤0.01% 1934
2024
Q2 		$1.1M Buy
+32,524
New +$1.8M 0.01% 977
2023
Q4 		– Sell
-294
Closed -$5K – 2725
2023
Q3 		$5K Buy
+294
New +$7.37K ﹤0.01% 2181
2021
Q4 		– Sell
-549
Closed -$193K – 3655
2021
Q3 		$193K Buy
+549
New +$216K ﹤0.01% 2704

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

HRT Financial's KRRO Position: Q2 2026 in Review

HRT Financial sold out of Korro Bio (KRRO) in Q2 2026, closing a stake of 10,790 shares — an estimated $122K sold.

HRT Financial first reported a position in KRRO in Q3 2021 and held it in 6 quarters. The position peaked at $1.1M in Q2 2024. 107 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

  • HRT Financial reported no remaining Korro Bio position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 10,790 Korro Bio shares in Q2 2026, an estimated $122K.
  • HRT Financial first reported a position in Korro Bio in Q3 2021 and held it in 6 quarters.
  • HRT Financial's Korro Bio position peaked at $1.1M in Q2 2024.
  • 107 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.